Bayer Appoints New Board Members
This article was originally published in Scrip
Following a reorganization of its business units, Bayer AG. has appointed Dieter Weinand (current head of Pharmaceuticals), Erica Mann (head of Consumer Health) and Liam Condon (head of CropScience) to its board – effective Jan. 1, 2015. Furthermore, Hartmut Klusik, who will be succeeding Michael Konig, has been appointed labor director and board member responsible for human resources, technology and sustainability.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.